Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Eur J Clin Invest 2012; 42 (9): 992–999 Background Postprandial hyperlipidemia partially refers to the postprandial accumulation of chylomicrons and chylomicron remnants (CM‐R). Many in vitro studies have shown that CM‐R has highly atherogenic properties, but consensus is lacking on whether CM‐R accumulation correlates with the development of atherosclerotic cardiovascular diseases. We investigated the correlation between CM‐R accumulation and the prevalence of coronary artery disease (CAD). Design Subjects who received a coronary angiography and did not take any lipid‐lowering drugs (n = 189) were enrolled. Subjects with coronary artery stenosis (≥ 75%) were diagnosed as CAD. Biochemical markers for glucose and lipid metabolism including fasting apolipoprotein (apo) B‐48 concentration were compared between CAD patients (n = 96) and age‐, sex‐, and body mass index (BMI)‐matched non‐CAD subjects without overt coronary stenosis (< 75%) (n = 67). We tried to determine which metabolic parameters were correlated with the prevalence of CAD by multiple logistic regression analysis, and whether or not the combination of high apo B‐48 and other coronary risk factors (high triglyceride, low HDL‐C, high HbA1c or low adiponectin levels) increased the prevalence of CAD. Results Fasting serum apo B‐48 levels were significantly higher in CAD patients than in non‐CAD subjects (3·9 ± 2·4 vs. 6·9 ± 2·6 μg/mL, P < 0·0001) and had the most significant correlation with the existence of CAD. The clustering of high fasting apo B‐48 levels (> 4·34 μg/mL, the cut‐off value) and other coronary risk factors were found to be associated with a stronger risk of CAD compared with single high fasting apo B‐48 levels. Conclusion Fasting serum apo B‐48 levels significantly correlated with the prevalence of CAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360
Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284
Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146
Identification of lipoproteins of intestinal origin in human atherosclerotic plaque
Pal, S., Semorine, K., Watts, G. F., & Mamo, J. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.120 · Cited by 107
Cited by
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Self-citationPostprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145
Self-citationArai, H., Yamashita, S., Yokote, K., Araki, E., Suganami, H., & Ishibashi, S. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.03.032 · Cited by 124
Self-citationPemafibrate Tends to have Better Efficacy in Treating Dyslipidemia than Fenofibrate
Wang, H., Li, H., Zhou, Y., Liu, J., Wang, F., & Zhao, Q. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612825666191126102943 · Cited by 11
Metadata
- Authors
- Masuda, D., Sugimoto, T., Tsujii, K., Inagaki, M., Nakatani, K., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Ohama, T., Nishida, M., Ishigami, M., Kawamoto, T., Matsuyama, A., Sakai, N., Komuro, I., & Yamashita, S.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2012-05-15
- Volume
- 42
- Issue
- 9
- Pages
- 992-999
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1518445845
- Cited by
- 60
- References
- 5
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence. https://app.cochat.ai/papers/10.1111/j.1365-2362.2012.02687.x
- The paper
- Masuda, D., Sugimoto, T., Tsujii, K., Inagaki, M., Nakatani, K., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Ohama, T., Nishida, M., Ishigami, M., Kawamoto, T., Matsuyama, A., Sakai, N., Komuro, I., & Yamashita, S. (2012). Correlation of fasting serum apolipoprotein B‐48 with coronary artery disease prevalence. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.2012.02687.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.